Symbol="RNAZ"
AssetType="Common Stock"
Name="Transcode Therapeutics Inc"
Description="TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic diseases. The company is headquartered in Boston, Massachusetts."
CIK="1829635"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6 LIBERTY SQUARE, #2382, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4629000"
EBITDA="-19982780"
PERatio="None"
PEGRatio="None"
BookValue="-0.299"
DividendPerShare="0"
DividendYield="0"
EPS="-25.21"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.028"
ReturnOnEquityTTM="-2.256"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-25.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.719"
EVToRevenue="-"
EVToEBITDA="-0.527"
Beta="None"
num_52WeekHigh="31.6"
num_52WeekLow="2.23"
num_50DayMovingAverage="4.244"
num_200DayMovingAverage="10.24"
SharesOutstanding="1801200"
DividendDate="None"
ExDividendDate="None"
symbol="RNAZ"
open="2.63"
high="2.74"
low="2.54"
price="2.64"
volume="114546.00"
latest_trading_day="2023-07-13"
previous_close="2.83"
change="-0.19"
change_percent="-6.7138%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="89"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="11"
Volume_recent_avg="705530"
Change_recent_avg="-0.03"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-1.61"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="11"
Aroon_momentum_negative="89"
image_negative_thumbnail_id_1="493"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_negative_thumbnail_id_2="1087"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_neutral_thumbnail_id_1="579"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="624"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_positive_thumbnail_id_2="954"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
